155 related articles for article (PubMed ID: 32347356)
1. Diagnostic impact of ascites cytology in 941 patients: malignancy rates and time of detection in ovarian cancer relative to other tumor types.
Krugmann J; Schwarz CL; Melcher B; Sterlacci W; Vieth M; Rösch S; Lermann J
Arch Gynecol Obstet; 2020 Jun; 301(6):1521-1532. PubMed ID: 32347356
[TBL] [Abstract][Full Text] [Related]
2. Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015.
Krugmann J; Schwarz CL; Melcher B; Sterlacci W; Ozalinskaite A; Lermann J; Agaimy A; Vieth M
Arch Gynecol Obstet; 2019 Feb; 299(2):515-523. PubMed ID: 30415435
[TBL] [Abstract][Full Text] [Related]
3. [Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].
Barbare JC; Diab G; Delavenne J; Philippe JM; Vorhauer W; Latrive JP; Capron JP
Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):251-6. PubMed ID: 2619252
[TBL] [Abstract][Full Text] [Related]
4. Malignancy-related ascites and ascitic fluid "humoral tests of malignancy".
Runyon BA
J Clin Gastroenterol; 1994 Mar; 18(2):94-8. PubMed ID: 8189030
[TBL] [Abstract][Full Text] [Related]
5. Detection of allelic imbalance in ascitic supernatant by digital single nucleotide polymorphism analysis.
Chang HW; Ali SZ; Cho SK; Kurman RJ; Shih IeM
Clin Cancer Res; 2002 Aug; 8(8):2580-5. PubMed ID: 12171887
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
7. Ascitic fluid analysis in malignancy-related ascites.
Runyon BA; Hoefs JC; Morgan TR
Hepatology; 1988; 8(5):1104-9. PubMed ID: 3417231
[TBL] [Abstract][Full Text] [Related]
8. Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.
Castaldo G; Oriani G; Cimino L; Topa M; Mostarda I; Castellano L; Del Vecchio-Blanco C; Budillon G; Salvatore F; Sacchetti L
Clin Chem; 1994 Mar; 40(3):478-83. PubMed ID: 8131285
[TBL] [Abstract][Full Text] [Related]
9. How valuable is ascitic cytology in the detection and management of malignancy?
Karoo RO; Lloyd TD; Garcea G; Redway HD; Robertson GS
Postgrad Med J; 2003 May; 79(931):292-4. PubMed ID: 12782778
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell carcinoma presenting as malignant ascites: A case report and review of literature.
Policarpio-Nicolas ML; Avery DL; Hartley T
Cytojournal; 2015; 12():19. PubMed ID: 26425135
[TBL] [Abstract][Full Text] [Related]
11. Cytological Findings of Ascitic Fluid with a Malignant Ovarian Steroid Cell Tumor: A Case Report and Literature Review.
Kosaka N; Hasegawa K; Kiuchi K; Ochiai S; Nagai T; Machida H; Imai Y; Fukasawa I
Acta Cytol; 2017; 61(2):165-171. PubMed ID: 28343229
[TBL] [Abstract][Full Text] [Related]
12. Malignant ascites. Clinical and experimental observations.
Garrison RN; Kaelin LD; Galloway RH; Heuser LS
Ann Surg; 1986 Jun; 203(6):644-51. PubMed ID: 3718029
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of fibronectin as a marker of malignant ascites.
Siddiqui RA; Kochhar R; Singh V; Rajwanshi A; Goenka MK; Mehta SK
J Gastroenterol Hepatol; 1992; 7(2):161-4. PubMed ID: 1571498
[TBL] [Abstract][Full Text] [Related]
14. Cell adhesion molecule profiles, proliferation activity and p53 expression in advanced epithelial ovarian cancer induced malignant ascites-Correlation of tissue microarray and cytology microarray.
Toth L; Nagy B; Mehes G; Laszlo E; Molnar PP; Poka R; Hernadi Z
Pathol Res Pract; 2018 Jul; 214(7):978-985. PubMed ID: 29801775
[TBL] [Abstract][Full Text] [Related]
15. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
17. Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy.
Hatzipetros I; Gocze PM; Cziraky K; Kovacs K; Kalman E; Farkas B
Reprod Biol Endocrinol; 2013 Sep; 11():91. PubMed ID: 24028152
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Impact of Peritoneal Fluid Cytology in the Setting of Pediatric Uterine Adnexal Biopsy or Resection.
Vadva Z; Laufer MR; Weldon CB; Frazier AL; Vargas SO
Pediatr Dev Pathol; 2016; 19(5):401-408. PubMed ID: 26579785
[TBL] [Abstract][Full Text] [Related]
19. [Ascites May Provide Useful Information for Diagnosis of Ovarian Cancer].
Stuchlíková E; Zahradníková M; Nenutil R; Valík D; Vojtěšek B; Novotný M; Hernychova L
Klin Onkol; 2017; 30(Supplementum1):187-190. PubMed ID: 28471203
[TBL] [Abstract][Full Text] [Related]
20. The ascites N-glycome of epithelial ovarian cancer patients.
Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V
J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
